BioSpace News Archive

DoubleRainbow Biosciences (“Double Rainbow”), a sustainable biotech company harnessing bioengineering to improve the quality of human health, announced today a new research collaboration with Kelai Pharmaceuticals (“Kelai”) to explore the potential of biosynthetic kavalactone therapeutics. Kelai will include one of Double Rainbow’s molecules in their ongoing cell transcriptome study.

As per report study, the global MRI motion tracking systems market was surpassed at USD 2.83 million in 2021 and is expected to hit around USD 12.89 million by 2030, growing at a CAGR of 18.35% from 2022 to 2030

Remote patient monitoring allows the healthcare professionals to monitor disease and symptom progression remotely and engage with patients virtually to modify the care plans and provide education on self-care, based on changes in the patient’s condition.

Diabetes, obesity, pressure ulcers, and age-related vascular disorders frequently induce hard wounds, and their prevalence is increasing globally.

According to Vision Research Reports, the global nuclear magnetic resonance spectroscopy market was surpassed at USD 657.3 million in 2021 and is expected to hit around USD 1,025.6 million by 2030, growing at a CAGR of 5.07% from 2022 to 2030

The bacterial & viral specimen collection market has been projected to experience various growth opportunities in the forthcoming years.

The global cutaneous squamous cell carcinoma treatment market is likely to show upward revenues curve during the forecast period of 2021 to 2031.

The osteoporosis drugs market has been anticipated to grow at a significant speed in the forthcoming years.

Avenge Bio, Inc., (“Avenge” or the “Company”) today announced a publication in the peer-reviewed journal Clinical Cancer Research describing the foundational, preclinical data establishing the efficacy and safety of pleural administered LOCOcyte™ for the treatment of pleural malignant mesothelioma.

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be sponsoring, presenting and hosting a booth this week at the 14th Annual Next Generation Dx Summit.